SensoDetect AB

SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.

Quotes

Board

CEO

Chairperson of the Board

  • Karl Lundin

Board

  • Hu Jin
  • Johan Peter Morgan Friberg
  • Wendi Ma

Videos

1 / 4
Interview SensoDetect - Stora Aktiedagarna Stockholm 28 november 2024
CompanyPresentation SensoDetect
CompanyPresentation SensoDetect - Presentation BioStock Live - 2018-11-27
Interview SensoDetect AB intervju
*Powered by Modular Finance